Low molecular weight non-peptide inhibitors of platelet aggregation ba
sed on rigid bycyclic scaffolds are described. Consideration of the re
ported conformational preferences of 1-alkyl-3-carbonyl pyrroles led t
o the synthesis of pyrrolopiperazinone 2a which was shown to be a pote
nt, selective antagonist.